Projects per year
Abstract
Nitrile-aminothiol conjugation (NATC) stands out as a promising biocompatible ligation technique due to its high chemo-selectivity. Herein we investigated the reactivity and substrate scope of NAT conjugation chemistry, thus developing a novel pH dependent orthogonal NATC as a valuable tool for chemical biology. The study of reaction kinetics elucidated that the combination of heteroaromatic nitrile and aminothiol groups led to the formation of an optimal bioorthogonal pairing, which is pH dependent. This pairing system was effectively utilized for sequential and dual conjugation. Subsequently, these rapid (≈1 h) and high yield (>90 %) conjugation strategies were successfully applied to a broad range of complex biomolecules, including oligonucleotides, chelates, small molecules and peptides. The effectiveness of this conjugation chemistry was demonstrated by synthesizing a fluorescently labelled antimicrobial peptide-oligonucleotide complex as a dual conjugate to imaging in live cells. This first-of-its-kind sequential NATC approach unveils unprecedented opportunities in modern chemical biology, showcasing exceptional adaptability in rapidly creating structurally complex bioconjugates. Furthermore, the results highlight its potential for versatile applications across fundamental and translational biomedical research.
Original language | English |
---|---|
Article number | e202401674 |
Number of pages | 10 |
Journal | Chemistry - A European Journal |
Volume | 30 |
Issue number | 6 |
DOIs | |
Publication status | Published - 19 Aug 2024 |
Keywords
- Antibiotics
- Antisense oligonucleotides
- Bioorthogonal conjugations
- Nitrile-aminothiol conjugation peptides
-
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Craik, D. J., Payne, R., Belov, K., Jolliffe, K. A., New, E., Fairlie, D., King, G. F., Henriques, S. T., Otting, G., Malins, L., Jackson, C., Cryle, M., Challis, G., Colgrave, M., Ploegh, H., Baker, D. A., Suga, H., Davis, B. G., Pentelute, B., van der Donk, W., Tavassoli, A. & Savage, G.
23/12/20 → 21/01/28
Project: Research
-
Targeting pan-drug resistant (PDR) Gram-negative pathogens with novel anti-sense drug technology
Patil, N.
1/01/19 → 31/12/22
Project: Research